| Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer B Fisher, S Anderson, J Bryant, RG Margolese, M Deutsch, ER Fisher, ... New England Journal of Medicine 347 (16), 1233-1241, 2002 | 7995 | 2002 |
| Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation B Fisher, JH Jeong, S Anderson, J Bryant, ER Fisher, N Wolmark New England Journal of Medicine 347 (8), 567-575, 2002 | 1786 | 2002 |
| Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2–positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG … EA Perez, EH Romond, VJ Suman, JH Jeong, G Sledge, CE Geyer Jr, ... Journal of clinical oncology 32 (33), 3744, 2014 | 1101 | 2014 |
| Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2–positive breast cancer: joint analysis of data from NCCTG … EA Perez, EH Romond, VJ Suman, JH Jeong, NE Davidson, CE Geyer Jr, ... Journal of clinical oncology 29 (25), 3366, 2011 | 941 | 2011 |
| Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus … EH Romond, JH Jeong, P Rastogi, SM Swain, CE Geyer Jr, MS Ewer, ... Journal of Clinical Oncology 30 (31), 3792, 2012 | 576 | 2012 |
| Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast … IL Wapnir, SJ Anderson, EP Mamounas, CE Geyer Jr, JH Jeong, ... Journal of Clinical Oncology 24 (13), 2028-2037, 2006 | 540 | 2006 |
| Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and … SJ Anderson, I Wapnir, JJ Dignam, B Fisher, EP Mamounas, JH Jeong, ... Journal of Clinical Oncology 27 (15), 2466, 2009 | 510 | 2009 |
| Overexpression of Glut‐1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma M Kunkel, TE Reichert, P Benz, HA Lehr, JH Jeong, S Wieand, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 494 | 2003 |
| Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy … A Taghian, JH Jeong, E Mamounas, S Anderson, J Bryant, M Deutsch, ... Journal of Clinical Oncology 22 (21), 4247-4254, 2004 | 438 | 2004 |
| Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project … EP Mamounas, JH Jeong, DL Wickerham, RE Smith, PA Ganz, SR Land, ... Journal of Clinical Oncology 26 (12), 1965-1971, 2008 | 426 | 2008 |
| Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials B Fisher, JH Jeong, J Bryant, S Anderson, J Dignam, ER Fisher, ... The Lancet 364 (9437), 858-868, 2004 | 411 | 2004 |
| Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer SM Swain, JH Jeong, CE Geyer Jr, JP Costantino, ER Pajon, ... New England Journal of Medicine 362 (22), 2053-2065, 2010 | 388 | 2010 |
| Anthracyclines in early breast cancer: The abc trials—usor 06-090, nsabp b-46-i/usor 07132, and nsabp b-49 (nrg oncology) JL Blum, PJ Flynn, G Yothers, L Asmar, CE Geyer Jr, SA Jacobs, ... Journal of clinical oncology 35 (23), 2647, 2017 | 293 | 2017 |
| Updated results of the combined analysis of NCCTG N9831 and NSABP B-31 adjuvant chemotherapy with/without trastuzumab in patients with HER2-positive breast cancer EA Perez, EH Romond, VJ Suman, J Jeong, NE Davidson, CE Geyer, ... Journal of clinical oncology 25 (18_suppl), 512-512, 2007 | 287 | 2007 |
| Population-based study of competing mortality in head and neck cancer BS Rose, JH Jeong, SK Nath, SM Lu, LK Mell Journal of clinical oncology 29 (26), 3503-3509, 2011 | 208 | 2011 |
| Breast cancer adjuvant therapy: time to consider its time-dependent effects I Jatoi, WF Anderson, JH Jeong, CK Redmond Journal of clinical oncology 29 (17), 2301, 2011 | 204 | 2011 |
| Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer B Fisher, JH Jeong, J Dignam, S Anderson, E Mamounas, DL Wickerham, ... JNCI Monographs 2001 (30), 62-66, 2001 | 204 | 2001 |
| Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and … AG Taghian, JH Jeong, EP Mamounas, DS Parda, M Deutsch, ... Journal of clinical oncology 24 (24), 3927-3932, 2006 | 154 | 2006 |
| Parametric regression on cumulative incidence function JH Jeong, JP Fine Biostatistics 8 (2), 184-196, 2007 | 139 | 2007 |
| Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial EP Mamounas, H Bandos, BC Lembersky, JH Jeong, CE Geyer, ... The Lancet Oncology 20 (1), 88-99, 2019 | 131 | 2019 |
